Finch Therapeutics has joined the ranks of biotechs that are narrowing their focus. With its lead program under clinical hold, the microbiome specialist has pulled out of a planned study in chronic ...
A week after taking back two unhatched inflammatory bowel assets from Takeda, Finch Therapeutics is cutting more than a third of its staff and delaying clinical trial plans to stave off rising costs.
A hauntingly beautiful story full of death and unexpected twists earns the number 9 spot on GameSpot's game of the year list for 2017. On the final episode of Reboot's second season, Mike and Jake ...
(CN) — On Thursday, the European Union's top court ruled that Malta’s law allowing the live capture of finches — a cultural tradition dating back centuries — violates the EU’s directive to protect ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results